We read with interest the letter by Dr Chaudhry1 entitled ‘Adverse reaction to Nexplanon^® ’ in the July 2013 issue of the Journal. Over the past 5 months our department has experienced certainly two, possibly three, incidents of skin infection secondary to a contraceptive implant in patients with a comorbidity of atopic eczema.

The first case was a 15-year-old girl who developed an infection around 10 days post-subdermal implant fit. A skin swab revealed a growth of Staphylococcus aureus sensitive to both flucloxacillin and co-amoxiclav. The patient initially received oral flucloxacillin and then a secondary treatment with oral co-amoxiclav. However, despite the organism sensitivities the wound …